Key technologies and capabilities for this role
Common questions about this position
The position is located in Redwood City, CA (Hybrid) or Remote (USA).
This information is not specified in the job description.
The role requires a strong background in clinical research and molecular diagnostics, with proven ability to drive study design and implementation in a fast-paced, scientifically rigorous environment. Experience collaborating with cross-functional teams, external stakeholders like KOLs and Investigators, and supporting regulatory discussions is essential.
Karius fosters a collaborative, cross-functional team environment including medical, clinical, commercial, and product teams, focused on innovation in genomic sequencing and machine learning to conquer infectious diseases. The culture emphasizes scientific rigor, mission-driven work with direct life-changing impact, and communication across all organizational levels.
A strong candidate has a passion for clinical research, experience designing and executing studies in molecular diagnostics, and the ability to collaborate with cross-functional teams and external stakeholders while influencing decision-making in a fast-paced environment.
Non-invasive diagnostic tests for infections
Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, which detects over 1,000 pathogens from a single blood sample. This non-invasive test is quick and helps clinicians treat hospitalized patients by reducing the need for multiple invasive tests that can delay treatment. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, providing insights into the pathogens responsible for infections. Karius sells these diagnostic tests to healthcare providers, aiming to offer a faster and less invasive alternative to traditional methods, ultimately saving lives and reducing healthcare costs. The company employs proprietary machine learning algorithms to analyze genomic data in real time, continuously updating its reference genome databases to enhance its diagnostic capabilities.